ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $62,152 | +130.2% | 1,419 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $27,000 | -3.6% | 1,419 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $28,000 | -33.3% | 1,419 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $42,000 | +27.3% | 1,419 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $33,000 | -25.0% | 1,419 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $44,000 | -12.0% | 1,419 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $50,000 | 0.0% | 1,419 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $50,000 | -5.7% | 1,419 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $53,000 | +60.6% | 1,419 | +45.7% | 0.00% | +100.0% |
Q3 2020 | $33,000 | +26.9% | 974 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $26,000 | +62.5% | 974 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $16,000 | -5.9% | 974 | +41.6% | 0.00% | 0.0% |
Q4 2019 | $17,000 | +21.4% | 688 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $14,000 | -36.4% | 688 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $22,000 | 0.0% | 688 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $22,000 | +29.4% | 688 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $17,000 | -26.1% | 688 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $23,000 | -4.2% | 688 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $24,000 | – | 688 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
PA Capital LLC | 14,692 | $360,000 | 0.38% |
Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |